NCT06937866
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06937866
Title Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Indiana University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.